Respiratory viruses such as rhinoviruses can exacerbate allergen-driven asthma. In Science Translational Medicine, Beale et al. report that patients with atopic asthma produce more IL-25 in response to infection with rhinovirus than do healthy people, which contributes to the severity of allergic inflammation and airway hyper-reactivity. Infection with rhinovirus also enhances the production of IL-25 by bronchial epithelial cells in mouse allergy models. This response correlates with greater production of type 2 cytokines, enhanced recruitment of leukocytes and accumulation of cells expressing IL-17RB (the IL-25 receptor) in the infected lungs. However, such allergen-sensitized mice have higher viral loads in their airway tissues, which suggests that this response interferes with antiviral immunity. Blocking IL-17RB in the mouse lungs relieves the exacerbation of asthma and diminishes the viral load. Thus, targeting IL-25 signaling pathways may have therapeutic effects that lessen the disease severity and morbidity associated with viral exacerbation of asthma.
Rights and permissions
About this article
Cite this article
Dempsey, L. Rhinoviruses induce IL-25. Nat Immunol 16, 64 (2015). https://doi.org/10.1038/ni.3067
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.3067